Utilization of Kanglaite Injections in Lung Cancer Patients in 11 Hospitals of Zhejiang from 2009 to 2013
- VernacularTitle:2009~2013年浙江省11家医院肺癌患者康莱特注射液利用调查
- Author:
Fangjun CHEN
;
Xiaofang ZHOU
;
Zeng WANG
- Publication Type:Journal Article
- Keywords:
Kanglaite injections;
Lung cancer;
Drug application
- From:
China Pharmacist
2014;(12):2107-2109
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the utilization of Kanglaite injections in lung cancer patients in 11 hospitals of Zhejiang and analyze the prescription data. Methods: Totally 40-day prescription data of the patients with lung cancer in 11 hospitals of Zhejiang were withdrawn every year from 2009 to 2013. The data in respect of the consumption sum, DDDs, department distribution and medical insurance category of Kanglaite injections were analyzed. Results: The consumption sum of Kanglaite injections used in the patients with lung cancer in 11 hospitals of Zhejiang showed an upward trend year by year, the growth in 2011 and 2012 was the fastest, and the sum in 2012 was 1. 77-fold of that in 2009. The consumption sum proportion of Kanglaite injections in total amount of drug consumption rose after the first drop. The top 3 departments were oncology, radiotherapy and thoracic surgery in the five years. The dosage and DDDs of Kanglaite injections were also in an increase trend year by year, and the growth in 2011 and 2012 was the fastest. Conclusion:The utilization of Kanglaite injections in the patients with lung cancer in Zhejiang area shows a continuous rapid growth momentum, therefore, it is still essential to strengthen the reasonable application in clinics.
